Biotech Values

[jbog]

Blade

but I think if TEVA's generic Lovenox never gets approved, TEVA shareholder lawsuits will abound. We'll see, but it will take quite a while.

T-Enox is nothing more than a pimple on Teva's azz. Teva plate is so full and they'll have enough commotion for the next few years that their stockholders won't give a hoot.

Unless the FDA gave them a refusal (very remote), Teva can let this ANDA disappear.


I thought the recent TEVA stock decline had more to do with the EU conditions and the government raids on AZN and Nycomed.